Teva Under Federal Scrutiny Over Potential FCA Breaches
Teva Pharmaceuticals Industries Ltd. told investors it is under a federal investigation for potential violations of the False Claims Act, according to an annual report filed with the U.S. Securities and...To view the full article, register now.
Already a subscriber? Click here to view full article